Midwest Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Midwest Trust's NVS Position: Q2 2026 in Review
Midwest Trust reduced its Novartis (NVS) stake by 1.3% in Q2 2026, selling an estimated $457K and leaving 239,181 shares worth $37.5M. The position accounts for 0.42% of the portfolio, ranked #62.
Midwest Trust first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Midwest Trust held 239,181 shares of Novartis worth $37.5M as of Q2 2026.
- Midwest Trust sold 3,047 Novartis shares in Q2 2026, an estimated $457K.
- Novartis made up 0.42% of Midwest Trust's portfolio in Q2 2026, its #62 holding.
- Midwest Trust first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.